Use of plasmin for preventing of reducing the rate of the progression of nonproliferative diabetic retinopathy and the treatment of other ocular conditions

Details for Australian Patent Application No. 2006243986 (hide)

Owner Bausch & Lomb Incorporated

Inventors Comstock, Timothy L.; Levy, Brian; Mcintire, Gregory L.; Bartels, Stephen P.

Agent Spruson & Ferguson

Pub. Number AU-A-2006243986

PCT Pub. Number WO2006/122249

Priority 11/126,625 11.05.05 US

Filing date 10 May 2006

Wipo publication date 16 November 2006

International Classifications

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61P 27/02 (2006.01) Drugs for disorders of the senses

C12N 9/68 (2006.01) Enzymes, e.g. ligases (6.) - Plasmin, i.e. fibrinolysin

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/122249 Priority application(s): WO2006/122249

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006243987-Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof

2006243973-Tent fan